Placement of Balloon-expandable Intraluminal Stents in Iliac Arteries: First 171 Procedures

Julio C. Palmaz(The University of Texas at San Antonio), O. Garcia(The University of Texas Health Science Center at San Antonio), Richard A. Schatz(Arizona Heart Institute), Chet R. Rees(The University of Texas Health Science Center at San Antonio), T Roeren(The University of Texas Health Science Center at San Antonio), Goetz M. Richter(University of Freiburg), Gerd Noeldge(University of Freiburg), Geoffrey A. Gardiner(Thomas Jefferson University), Gary J. Becker(Indiana University Bloomington), Craig Walker, Jody Stagg, Barry T. Katzen(The Cardiac and Vascular Institute), Michael D. Dake(The Cardiac and Vascular Institute), R. M. Paolini(Instituto do Coração), Gordon K. McLean(Western Pennsylvania Hospital), Johannes Lämmer(University of Graz), Donald E. Schwarten(St Vincent Hospital), Fermin O. Tio(The University of Texas Health Science Center at San Antonio), Harlan D. Root(The University of Texas at San Antonio), Waid Rogers(The University of Texas Health Science Center at San Antonio)
Radiology
March 1, 1990
Cited by 189

Abstract

Balloon-expandable intraluminal stents were used to treat iliac artery stenoses or occlusions that failed to respond to conventional balloon angioplasty. One hundred seventy-one procedures were performed in 154 patients, of whom 48 had a limb at risk for amputation. Thirty-six had severe and 70 had moderate intermittent claudication. At the latest follow-up examination (average, 6 months; range, 1-24 months), 137 patients demonstrated clinical benefit, 113 of whom had become asymptomatic. Eleven patients showed no initial benefit, and six improved initially but later developed new vascular symptoms. Complications occurred in 18 patients. In three patients, complications were directly related to the device. Two occlusions were successfully recanalized, and an intramural collection of contrast material secondary to balloon perforation evolved favorably. The remaining patients had groin hematoma (n = 6), distal embolization (n = 4), extravasation (n = 2), transient renal failure (n = 1), pseudoaneurysm at the puncture site (n = 1), or subintimal dissection (n = 1). All stents have remained patent to the latest follow-up examination without evidence of migration or aneurysm formation.


Related Papers

No related papers found

Powered by citation graph analysis